Mom, 37, Saw Doctor 10 Times for Pain That Was Dismissed as a Hernia, Until a Female Doctor Took Her Seriously Yahoo Lifestyle Canada
Antibody–drug conjugates in gynaecological cancers: opportunities and challenges Nature
Monmouthshire mum says she may have avoided ovarian cancer if she lived in England BBC
IIQ: Results due within 13 days...? Next Investors
Small Biotech Context Therapeutics Reports 29% Response Rate In Ovarian Cancer Study Yahoo Finance
CNTX Hits Worst Day In History After Ovarian Cancer Trial Data — But Analysts See Buying Opportunity In Dip Yahoo Finance
New ovarian cancer treatment approved for NHS - the first for 20 years Sky News
Mirvetuximab Soravtansine/Carboplatin Improves ORR But Fails to Extend PFS in FRα-High Recurrent Ovarian Cancer OncLive
Nanowire device captures ovarian cancer biomarkers from blood serum Oncology Central
Targeting CDH6: A New ADC Approach in Gynecologic Cancer Cancer Nursing Today
TORL BioTherapeutics Presents Preliminary Safety and Efficacy Data of Ixotatug Vedotin (TORL-1-23) in Combination with Bevacizumab in Recurrent Ovarian Cancer at ESMO Gynaecological Cancers Congress 2026 PR Newswire
Weill Cornell Medicine Scientist Receives Award for Research on New Ovarian Cancer Targets WCM Newsroom
Christel Paganoni-Bruijns: World Ovarian Cancer Coalition Seeks Global Director of Communications Oncodaily
Oncoinvent achieves 50% recruitment milestone in Phase 2 ovarian cancer study of Radspherin® Yahoo Finance
St. Luke’s Physician Is Climbing High to Support Ovarian Cancer Patients Bucks County Herald newspaper
Mom, 37, Saw Doctor 10 Times for Pain That Was Dismissed as a Hernia, Until a Female Doctor Took Her Seriously People.com
‘How I knew I had endometrial cancer’: Survivors share their stories UT MD Anderson
New standards and new constraints redefine treatment sequencing in platinum-resistant ovarian cancer Nature
CellxLife Licenses Mayo Clinic FRα-Targeting Dendritic Cell Vaccine for Ovarian Cancer BioPharm International
A Common Cholesterol Drug May Weaken Ovarian Cancer Spread Duke Today
Compugen spotlights COM701 ovarian trial at ESMO congress Stock Titan
Johnson & Johnson wins talc bellwether trial over ovarian cancer claims Class Action Lawsuits
Allarity Therapeutics to Present Trial-in-Progress Poster GlobeNewswire
Circulating Immune Protein Signature Is Validated as OS Prognostic Tool in Recurrent Ovarian Cancer OncLive
Mocertatug Rezetecan Drives Rapid, Deep Responses in Platinum-Resistant Ovarian and Recurrent/Advanced Endometrial Cancer OncLive
From Ovarian to Endometrial Cancer, Experts Spotlight Standout Data From ASCO 2026 OncLive
Context Therapeutics Reports 29% Response Rate for CTIM-76 in Platinum-Resistant Ovarian Cancer Phase 1 Trial BioPharm International
Adiposity and cancer: systematic review and meta-analysis Nature
Ovarian Carcinosarcoma With Heterologous Chondrosarcomatous Differentiation: A Case Report and Review of Literature Cureus
Cedars-Sinai Launches New Cayton BRCA Center | Newswise Newswise
Oncoinvent reaches halfway point in ovarian cancer trial enrollment Investing.com
St. Luke’s physician to trek Peru’s mountains to support ovarian cancer patients WRNJ Radio
The antibody–drug conjugate era in gynaecological cancers ESMO Daily Reporter
Mom, 37, Saw Doctor 10 Times for Pain That Was Dismissed as a Hernia, Until a Female Doctor Took Her Seriously AOL.com
Allarity takes Phase 2 ovarian cancer trial to ESMO Congress Stock Titan
Why Angelina Jolie Said She’s Raised Her Kids “Preparing Them” For Her Death BuzzFeed
Breakthrough ovarian cancer drug offers patients more time and better quality of life BBC
The ovarian cancer drug market Nature
Rethinking ovarian cancer III: the past decade and future directions Nature
Data Updates Shift Treatment Standards in Gyn-Oncology Medscape